» Articles » PMID: 36902510

The Techniques of Blood Purification in the Treatment of Sepsis and Other Hyperinflammatory Conditions

Overview
Journal J Clin Med
Specialty General Medicine
Date 2023 Mar 11
PMID 36902510
Authors
Affiliations
Soon will be listed here.
Abstract

Even in the absence of strong indications deriving from clinical studies, the removal of mediators is increasingly used in septic shock and in other clinical conditions characterized by a hyperinflammatory response. Despite the different underlying mechanisms of action, they are collectively indicated as blood purification techniques. Their main categories include blood- and plasma processing procedures, which can run in a stand-alone mode or, more commonly, in association with a renal replacement treatment. The different techniques and principles of function, the clinical evidence derived from multiple clinical investigations, and the possible side effects are reviewed and discussed along with the persisting uncertainties about their precise role in the therapeutic armamentarium of these syndromes.

Citing Articles

Hemadsorption with CytoSorb in Infants with Sepsis: Non-Systematic Review of Cases.

Borankulova A, Sazonov V J Clin Med. 2024; 13(22).

PMID: 39597952 PMC: 11594804. DOI: 10.3390/jcm13226808.


The COSMOS Registry of CytoSorb Hemoadsorption Therapy in Critically Ill Patients: Protocol for an International, Prospective Registry.

Taccone F, Brunkhorst F, Bottari G, Hidalgo J, Kribben A, Teboul J JMIR Res Protoc. 2024; 13:e55880.

PMID: 39500494 PMC: 11576605. DOI: 10.2196/55880.


Effects of Oxiris Therapy on Cytokine Elimination after a LPS Infusion-An Experimental Animal Study.

Kalenka A, Arens P, Mullenbach R, Weigand M, Brune M, Fiedler-Kalenka M Int J Mol Sci. 2024; 25(17).

PMID: 39273234 PMC: 11394842. DOI: 10.3390/ijms25179283.


Extracorporeal organ support for critically ill patients: Overcoming the past, achieving the maximum at present, and redefining the future.

Papamichalis P, Oikonomou K, Xanthoudaki M, Valsamaki A, Skoura A, Papathanasiou S World J Crit Care Med. 2024; 13(2):92458.

PMID: 38855267 PMC: 11155504. DOI: 10.5492/wjccm.v13.i2.92458.


Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.

Ramasco F, Nieves-Alonso J, Garcia-Villabona E, Vallejo C, Kattan E, Mendez R J Pers Med. 2024; 14(2).

PMID: 38392609 PMC: 10890552. DOI: 10.3390/jpm14020176.

References
1.
Ankawi G, Fan W, Montin D, Lorenzin A, Neri M, Caprara C . A New Series of Sorbent Devices for Multiple Clinical Purposes: Current Evidence and Future Directions. Blood Purif. 2018; 47(1-3):94-100. DOI: 10.1159/000493523. View

2.
Livigni S, Bertolini G, Rossi C, Ferrari F, Giardino M, Pozzato M . Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: a multicenter randomised controlled clinical trial. BMJ Open. 2014; 4(1):e003536. PMC: 3902195. DOI: 10.1136/bmjopen-2013-003536. View

3.
Rimmele T, Hayi-Slayman D, Page M, Rada H, Monchi M, Allaouchiche B . [Cascade hemofiltration: principle, first experimental data]. Ann Fr Anesth Reanim. 2009; 28(3):249-52. DOI: 10.1016/j.annfar.2009.01.003. View

4.
Schultz P, Schwier E, Eickmeyer C, Henzler D, Kohler T . High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock: A retrospective cohort study. J Crit Care. 2021; 64:184-192. DOI: 10.1016/j.jcrc.2021.04.011. View

5.
Wendel Garcia P, Hilty M, Held U, Kleinert E, Maggiorini M . Cytokine adsorption in severe, refractory septic shock. Intensive Care Med. 2021; 47(11):1334-1336. PMC: 8409473. DOI: 10.1007/s00134-021-06512-0. View